Stock OTLK OUTLOOK THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Outlook Therapeutics, Inc.

Equities

OTLK

US69012T3059

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
9.1 USD +7.95% Intraday chart for Outlook Therapeutics, Inc. +12.48% +15.48%
Apr. 15 Outlook Therapeutics, Inc. announced that it has received $5.000002 million in funding from Syntone Ventures LLC CI
Apr. 15 Outlook Therapeutics, Inc. announced that it has received $5.000002 million in funding from Syntone Ventures LLC CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Outlook Therapeutics, Inc. Announces Executive Changes
CI
Outlook Therapeutics, Inc. Appoints Jedd Comiskey as Senior VP ? Head of Europe
CI
Outlook Therapeutics, Inc. Announces Executive Appointments
CI
Outlook Therapeutics, Inc. Appoints Glen Olsheim as Executive Director, Commercial Excellence
CI
Insider Buy: Outlook Therapeutics
MT
Outlook Therapeutics, Inc. Announces Appointment of Julia A. Haller as Board of Director
CI
Outlook Therapeutics, Inc. Appoints Alicia Tozier as Senior Vice President of Marketing and Market Access
CI
Insider Buy: Outlook Therapeutics
MT
Outlook Therapeutics, Inc. Announces Appointment of Joel Prieve as Senior Vice President, Commercial Operations
CI
Insider Buy: Outlook Therapeutics
MT
Outlook Therapeutics, Inc. Announces CEO Changes
CI
Outlook Therapeutics, Inc. Announces Management Changes
CI
Outlook Therapeutics, Inc. Announces Board Appointments
CI
Outlook Therapeutics, Inc. Appoints Andong Huang as Director
CI
Outlook Therapeutics, Inc. Announces Board Changes
CI
Outlook Therapeutics, Inc. Announces Board and Committee Changes
CI
Outlook Therapeutics, Inc. Announces Resignation of Joerg Windisch as Member of Board of Director
CI
Pankaj Mohan Not to Stand for Re-Election to the Board of Directors of Outlook Therapeutics, Inc
CI
Outlook Therapeutics, Inc. Announces Termination of Kenneth M. Bahrt as Chief Medical Officer
CI
Outlook Therapeutics, Inc. Announces Executive Appointments
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OTLK Stock
  4. News Outlook Therapeutics, Inc.
  5. Insiders